Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3104 (LINC03104) is a gene that encodes a long non-coding RNA transcript, classified as a long intergenic non-coding RNA (lincRNA). LincRNAs are autonomously transcribed RNAs longer than 200 nucleotides that do not overlap with annotated protein-coding genes. They are thought to play important regulatory roles in chromatin remodeling, transcriptional and post-transcriptional gene regulation, and nuclear architecture, though the specific functional relevance for LINC03104 remains unclear. LINC03104 does not encode a protein and, based on available information, is not a current therapeutic target, receptor, enzyme, or druggable molecule. Its role in disease, drug interactions, and use as a biomarker have not been established in the literature to date, and it is not specifically associated with any known disorders or molecular pathways as of the most recent genomic databases [1][5][7]. If more specific functional, disease, or drug-target information on LINC03104 becomes available in the future through experimental literature, these fields should be updated.
N/A — No drugs are known to target LINC03104.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3104 (LINC03104).